juna.ai | $7,500,000 | (Nov 21, 2024)
Distru | $6,000,000 | (Nov 21, 2024)
CellPoint Digital | $30,000,000 | (Nov 21, 2024)
Endowus
Singapore
- Singapore
- 09/08/2023
- Unknown
- $35,000,000
Endowus is a Singapore-based financial technology company that empowers people to take control of their financial future. The firm’s proprietary systems provide data-driven wealth advice in constructing personalised solutions. Its portfolios are built on access to institutional-quality financial products at the lowest cost possible.
Endowus is a fee-only independent advisor paid solely by its clients, allowing its advice to be unaffected by conflicts of interest. The firm provides its end-to-end digital solution to individual and institutional investors. It is licensed by the Monetary Authority of Singapore.
- Industry Financial Services
- Website https://endowus.com/
- LinkedIn https://www.linkedin.com/company/endowus/about/
Related People
Samuel RheeCo Founder
Singapore -
Singapore
Sam is Co-founder, Chairman & CIO at Endowus, the largest independent digital wealth platform in Asia with over U$5B of client assets and over U$95M of funding from some of the leading institutional investors and Asian families. It is the first digital advisor for Singapore's national social security system - the CPF, and the only digital wealth platform that allows you to invest your personal savings, private wealth and public pension in a seamless app experience. Endowus leads the proliferation of independent, conflict-free, fee-only financial advice in the region. He has three decades of experience in investing and finance and was formerly the CEO & Chief Investment Officer at Morgan Stanley Investment Management in Asia.
Four Growers, Inc. | $9,000,000 | (Nov 21, 2024)
Flywl | $7,000,000 | (Nov 21, 2024)
StoreCash | $3,700,000 | (Nov 21, 2024)
Magma Math | $40,000,000 | (Nov 21, 2024)
Prompt Security | $18,000,000 | (Nov 21, 2024)
Qminder | $3,164,550 | (Nov 21, 2024)
Konsileo | $10,122,225 | (Nov 21, 2024)
BrightAI | $15,000,000 | (Nov 21, 2024)
Valora Therapeutics, Inc. | $30,000,000 | (Nov 21, 2024)